S 288 United States Senate · 118th Congress

End Tuberculosis Now Act of 2024

The End Tuberculosis Now Act of 2024 establishes a U.S. government policy to accelerate global efforts to eliminate tuberculosis (TB), focusing on countries with the highest TB burden. It requires the President to set specific goals aligned with the World Health Organization's End TB Strategy, aiming to reduce TB deaths by 95% and TB incidence by 90% by 2035. The bill mandates annual reporting on U.S. TB assistance programs, including diagnostics, treatment, and prevention efforts, while requiring coordination with international partners like the World Health Organization and Stop TB Partnership. It emphasizes research for new TB diagnostics, treatments, and vaccines, and ensures TB programs can serve as platforms for responding to future respiratory pandemics.
Bill status passed 3 of 5 stages cleared
Introduction
Feb 2023
Committee Review
Sep 2024
Senate Passage
Sep 2024
House Passage
President
Introduced Feb 7, 2023 Last action Sep 23, 2024
Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
9
Key actions
3
Committee
2
Sep 19, 2024
Upper · Passed
Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S6317-6318)
upper
Sep 19, 2024
Upper · Passed
Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.
upper
Sep 19, 2024
Upper · Passed
Senate Committee on Foreign Relations discharged by Unanimous Consent.
upper
Feb 7, 2023
Committee
Read twice and referred to the Committee on Foreign Relations.
upper
Feb 7, 2023
Introduced
Introduced in Senate
upper
1 primary · 4 co-sponsors

Sponsors